Newgen Reports Powerful Growth, NAV Strengthened to $66.75
NewgenIVF Group reported a sharp swing to profitability for the first nine months of 2025, posting $17.5 million in...
PEDMARK® Study in Japan Shows Positive Hearing Loss Results
Fennec Pharmaceuticals reported positive topline results from the investigator-initiated STS-J01 Phase 2/3 study in Japan evaluating Pedmark (sodium thiosulfate)...
Animal-Free Alpha-Lactalbumin Deal Signed by Dyadic & BRIG
Dyadic Applied Biosolutions and Brig Bio have signed a development and commercialization agreement to produce recombinant bovine alpha-lactalbumin using...
Syndax Announces Participation at Evercore Health Conference
Syndax Pharmaceuticals will host a fireside chat at the Evercore ISI healthcare conference on December 4, 2025, coming just...
7Urgent Reminder: Adverum Stockholders Tender Shares to Lilly
Eli Lilly has launched a tender offer to acquire Adverum Biotechnologies for $3.56 per share in cash plus a...
Nurix to Webcast New Phase 1 Data for Bexobrutideg at ASH
Nurix Therapeutics will host a webcast on December 8 to review new and updated clinical data from its Phase...
Rakovina Therapeutics Reports Q3 2025 Financial Results
Rakovina Therapeutics reported Q3 2025 results alongside a slate of preclinical updates, highlighting progress across its AI-enabled DNA damage...
Scilex Completes Valuable Two-Tranche Investment in Datavault
Scilex Holding Company has closed the second tranche of its strategic investment in Datavault AI, funding the purchase of...
Hutchmed Highlights Clinical Data at 2025 ESMO & ASH Meetings
HUTCHMED will field a broad slate of oncology and hematology data at ESMO Asia and ASH 2025, spotlighting multiple...
US Reimbursement Changes Enable PFA Market Broadening
CMS has moved to add catheter ablation for atrial fibrillation to the list of reimbursable procedures in Ambulatory Surgical...